TARPLIN, DOWNS & YOUNG, LLC

Lobbying for NOVO NORDISK INC. · A global healthcare company focused on diabetes and other serious chronic diseases

Filing 4th Quarter - Report

4th Quarter (Oct 1 - Dec 31) 2025 · District of Columbia · House · Senate · $60,000.00 income · posted Jan 20, 2026

Lobbying activity 3

Health Issues

IRA, medication affordability and access, general diabetes prevention, obesity, impacts of drug shortages

Medicare/Medicaid

Treat and Reduce Obesity Act, obesity treatment

Budget/Appropriations

Federal budget issues

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.